PATENT CLAIM ANALYSIS

Application Number: 15759096
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2019-01
Patent Classification: ["424", "450000"]

Abstract:
A pharmaceutical composition comprising a lipid component, an amphiphilic emulsifier, a polar liquid carrier, and one or more electrolytes, where the amphiphilic emulsifier forms lipid carrying micelles or liposomes having a lipophilic core comprising the lipid component in the polar liquid carrier, and the micelles or liposomes have an average diameter between 90 nm and 120 nm and are stable for at least 4 weeks at room temperature. The pharmaceutical composition is free of hemoglobin and fluorocarbon and can be used for treating conditions related to lack of blood supply including but not limited to restoring normal cardiac rhythm after cardiac arrest or arrhythmia and to raise the blood pressure and correct hypovolemia.

Claim (Index 20):
A method for restoring normal cardiac rhythm after cardiac arrest or arrhythmia, comprising administering to a subject in need of such treatment, an effective amount of the pharmaceutical composition of  claim 12  by intra-arterial infusion.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 90.0
- Lexical Diversity: 1.55844
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13963521', '14534859', '14086492', '14534847', '13273471']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7833991182089195
- 35 USC 102 Novelty (BERT): 0.5375274762983371
- Combined Prediction Score: 0.7588119540178613
- Mean Citation Score: 402.42122
- Max Citation Score: 415.21793
- Similarity Product: 218.2770847642219

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test